2024-05-19
2024-05-19
November 21, 2024
Summary | |
---|---|
Cancer Type | Lung Cancer |
Grade | NA |
Stage | NA |
Ethnicity | Asian |
Gender | F |
Age | 38 |
Pathology Diagnosis | Carcinosarcoma. No malignant cells adjacent to bronchus stump. Regional LN: the second group LN (0/1), the forth group LN (0/3), inferior carina of trachea LN (0/2), the ninth group LN (0/2), the tenth group LN (0/1), the eleventh group LN (0/2). IHC results: CK(+), Vim(+), Act(-), NSE(-), Syn(-), CD56 (+/-), Chr-A (-). |
Biopsy Site | primary |
Treatment History | NA |
Pathology QC | Poorly differentiated tumor, giant cells, spindle cells and clear cells were observed (P12); Poorly differentiated squamous cell carcinoma (P13) |
Special Features | EML4-ALK fusion, Crizotinib resistant derivative of LU1656 |
Mouse Strain | Balb/c nu |
TMA | TMA-HP-LU-017 |
Viral Status in PDX | NA |
Available In | CB_CN |
RNA Seq | P10 |
Exome Seq | P11 |
Already Registered? Login
To view this data, close this window and Log In or Register for Access.
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy